Seeking Alpha - Healthcare IMV (IMV) said Monday it was notified by Nasdaq that its stock will be delisted as a result of the Nova Scotia Supreme Court granting the firm protection under CCAA.Trading of the...\n more…
Business Wire IMV Inc. (the Company or IMV) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today announced that it was notified by the Listing Qualifications...\n more…
Ticker Report HC Wainwright downgraded shares of IMV (TSX:IMV Get Rating) from a buy rating to a neutral rating in a research note released on Tuesday , PriceTargets.com reports. IMV Price Performance IMV stock opened at C$1.12 on Tuesday. The companys 50 day moving average is C$0.86 and its 200 ...\n more…
Zolmax HC Wainwright cut shares of IMV (TSX:IMV Get Rating) from a buy rating to a neutral rating in a report released on Tuesday , PriceTargets.com reports. IMV Stock Performance Shares of IMV stock opened at C$1.12 on Tuesday. The company has a debt-to-equity ratio of 1,231.01, a quick ratio of 2.32 and ...\n more…
Zolmax IMV (NASDAQ:IMV Get Rating) was downgraded by equities researchers at HC Wainwright from a buy rating to a neutral rating in a research note issued on Tuesday, The Fly reports. IMV Price Performance Shares of IMV stock opened at $0.82 on Tuesday. The firm has a market cap of $9.63 million, a price-...\n more…
Ticker Report IMV (NASDAQ:IMV Get Rating) was downgraded by stock analysts at HC Wainwright from a buy rating to a neutral rating in a report released on Tuesday, The Fly reports. IMV Price Performance NASDAQ:IMV opened at $0.82 on Tuesday. IMV has a 1-year low of $0.48 and a 1...\n more…